Molecule Details
| InChIKey | GGUSQTSTQSHJAH-UHFFFAOYSA-N |
|---|---|
| Compound Name | Eliprodil |
| Canonical SMILES | OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.89 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12869 |
|---|---|
| Drug Name | Eliprodil |
| CAS Number | 119431-25-3 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Eliprodil has been used in trials studying the treatment of Parkinson Disease and Movement Disorders. |
Categories: Central Nervous System Agents Compounds used in a research, industrial, or household setting Excitatory Amino Acid Agents Excitatory Amino Acid Antagonists Neuroprotective Agents Neurotransmitter Agents Protective Agents Receptors, Neurotransmitter
Cross-references: BindingDB: 50079387 ChEBI: 91784 CHEMBL28564 ChemSpider: 54708 PubChem:60703 PubChem:347829027 Wikipedia: Eliprodil